Literature DB >> 37067

Drugs, alcohol and driving.

T Seppala, M Linnoila, M J Mattila.   

Abstract

Driving a car is a complex psychomotor and perceptual task which is subject to impairment by many factors. Several workers have studied the potential effects of drugs and alchol in crash production by epidemiological and laboratory studies. Both types of studies have yielded useful data but their limitations must be borne in mind when applying the results in pratice. Alcohol is obviously the most common single cause of traffic accidents. A progessively increased risk with increasing blood alcohol levels is well documented; fatigue and/or drugs increase this risk. Drugs are related much more infrequently to traffic accidents although on the basis of statistics, there is a potential risk with drug use. However, drugs alone are not as important as alcohol. The most significant drugs as regards driving risk are obviously certain antianxiety agents, hypnotics, stimulants, hallucinogens, marihuana, lithium and narcotic analgesics, as well as ganglionic blocking agents, insulin and sulphonylurea derivates. Patients should not drive after taking these drug until they are objectively fully alert and capable. Anticholinergics, antihistamines, antidepressants, antipsychotics, phenybutazone, indomethacin, alpha-methyldopa, and beta-blockers may in some cases cause central side effects (e.g. drowsiness) strong enough to affect driving performance. After starting therapy with these drugs, or after a significant change in dose, driving should be avoided until it is known that unwanted effects do not occur. Psychotropic drugs may enhance the deleterious effect of alcohol, and with most hypnotics there is still an effect the next morning. Some drugs (e.g. anticonvulsants or antiparkinsonian drugs) may make driving safer, but the disease (epilepsy, Parkinsonism, cardiovascular diseases, psychic disorders, etc.) ofter precludes driving. Clinicians should warn their patients about an impairment of driving skills if this is likely to occur due to the drug or the illness concerned.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37067     DOI: 10.2165/00003495-197917050-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  123 in total

1.  [Influencing achievement motivation through psychopharmaceuticals: I. The 4 primary thematic-picture variables].

Authors:  G Bäumler
Journal:  Z Exp Angew Psychol       Date:  1975

2.  Differences between light and sound sleepers in the residual effects of nitrazepam.

Authors:  A W Peck; C E Bye; R Claridge
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

3.  Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam.

Authors:  K Seppälä; K Korttila; S Häkkinen; M Linnoila
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

4.  [Physiological changes in the performance of older test persons during continuous tracking tasks following administration of a central nervous system stimulants].

Authors:  H Strasser; W Müller-Limmroth
Journal:  Arzneimittelforschung       Date:  1973-03

5.  Fatal traffic accidents: deterrents to an emergency approach.

Authors:  M L Selzer
Journal:  Univ Mich Med Cent J       Date:  1968 Mar-Apr

6.  Dose-response analysis of the effects of tetrahydrocannabinol in man.

Authors:  G F Kiplinger; J E Manno; B E Rodda; R B Forney
Journal:  Clin Pharmacol Ther       Date:  1971 Jul-Aug       Impact factor: 6.875

7.  Lorazepam on visuo-motor co-ordination and visual function in man.

Authors:  R W Bell; D S Dickie; J Stewart-Jones; P Turner
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

8.  The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency.

Authors:  C W Ogle; P Turner; H Markomihelakis
Journal:  Psychopharmacologia       Date:  1976-04-15

9.  Marijuana and driving in real-life situations.

Authors:  H Klonoff
Journal:  Science       Date:  1974-10-25       Impact factor: 47.728

10.  Operating room nurses' psychomotor and driving skills after occupational exposure to halothane and nitrous oxide.

Authors:  K Korttila; P Pfäffli; M Linnoila; E Blomgren; H Hänninen; S Häkkinen
Journal:  Acta Anaesthesiol Scand       Date:  1978       Impact factor: 2.105

View more
  19 in total

1.  Objective and subjective assessments of the effects of flupentixol and benzodiazepines on human psychomotor performance.

Authors:  M J Mattila; M Mattila; K Aranko
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Benzodiazepines: clinical pharmacology and therapeutic use.

Authors:  C Bellantuono; V Reggi; G Tognoni; S Garattini
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

3.  Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects.

Authors:  U Saarialho-Kere
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

Review 4.  Low blood alcohol concentrations and driving impairment. A review of experimental studies and international legislation.

Authors:  S D Ferrara; S Zancaner; R Giorgetti
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

5.  No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study.

Authors:  F Kamali
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Interaction of diazepam or lorazepam with alcohol. Psychomotor effects and bioassayed serum levels after single and repeated doses.

Authors:  K Aranko; T Seppälä; J Pellinen; M J Mattila
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep.

Authors:  T Seppälä; E Nuotto; K Korttila
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

8.  Effects of depot neuroleptics on driving performance in chronic schizophrenic patients.

Authors:  K R Wylie; D J Thompson; H J Wildgust
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

9.  Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol a placebo controlled cross-over study.

Authors:  T Seppälä; C Strömberg; I Bergman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  The role of drugs in the treatment of alcoholism.

Authors:  J E Peachey; C A Naranjo
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.